Facet browsing currently unavailable
Page 10 of 3821 results
Sort by: relevance publication year
New developments around histamine H3receptor antagonists/inverse agonists: a patent review (2010 – present) JOURNAL ARTICLE published January 2014 in Expert Opinion on Therapeutic Patents |
Malaria transmission blocking compounds: a patent review JOURNAL ARTICLE published 3 June 2022 in Expert Opinion on Therapeutic Patents |
GlaxoSmithKline’s CCR3 chemokine receptor antagonists JOURNAL ARTICLE published April 2004 in Expert Opinion on Therapeutic Patents |
Novel activators of dendritic cells as fundamental tools in immunotherapy JOURNAL ARTICLE published September 2001 in Expert Opinion on Therapeutic Patents |
Engraftable human neural stem cells JOURNAL ARTICLE published April 2000 in Expert Opinion on Therapeutic Patents |
Annotated Patent Selections JOURNAL ARTICLE published 2004 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published October 2005 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published August 2006 in Expert Opinion on Therapeutic Patents |
Annotated Patent Selections JOURNAL ARTICLE published March 2000 in Expert Opinion on Therapeutic Patents |
Editorial Biologicals & Immunologicals: Patenting combinatorial libraries and associated technologies JOURNAL ARTICLE published September 1996 in Expert Opinion on Therapeutic Patents |
Semisynthetic derivatives of mannopeptimycin antibiotics active against multi-drug resistant Gram-positive bacteria JOURNAL ARTICLE published August 2003 in Expert Opinion on Therapeutic Patents |
New long acting β2agonists JOURNAL ARTICLE published February 2003 in Expert Opinion on Therapeutic Patents |
Novel crystalline form of 3,5-dibromo-N-[(2S)- 2-(-4-fluorophenyl)-4- (3-morpholin-4-ylaztidin-1-yl)butyl]-N-methylbenzamide JOURNAL ARTICLE published February 2008 in Expert Opinion on Therapeutic Patents |
Phenyl acetic acid derivatives as inhibitors of leukotriene synthesis JOURNAL ARTICLE published October 1994 in Expert Opinion on Therapeutic Patents |
British Biotech: how much value is there in metalloproteinase inhibitors? JOURNAL ARTICLE published July 1997 in Expert Opinion on Therapeutic Patents |
Diabetes area patent participation analysis – part II: years 2011-2016 JOURNAL ARTICLE published February 2018 in Expert Opinion on Therapeutic Patents |
Anti-aggregatory drugs: I. Platelet receptor antagonists JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents |
N-Acylphenylalanines as antagonists of VLA-4/VCAM-1 JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published September 2006 in Expert Opinion on Therapeutic Patents |
N-substituted quinuclidinol esters as potential therapeutic antimuscarinic agents JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Patents |